WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013144085) 4-OXO-2-PENTENOIC ACID AND LIVER DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/144085    International Application No.:    PCT/EP2013/056272
Publication Date: 03.10.2013 International Filing Date: 25.03.2013
IPC:
A61K 31/19 (2006.01), A23L 1/00 (2006.01), A61P 1/16 (2006.01), A61K 35/00 (2006.01), C12R 1/00 (2006.01)
Applicants: NESTEC S.A. [CH/CH]; IAM Department Avenue Nestlé 55 CH-1800 Vevey (CH)
Inventors: ARCE VERA, Francia Jacqueline; (CH).
BOURQUI, Bertrand; (CH).
BUETLER, Timo; (CH).
DUBOUX, Stéphane; (CH).
FOATA, Francis; (CH).
GUY, Philippe Alexandre; (CH).
PAGE, Nicolas; (CH).
REZZI, Serge André Dominique; (CH)
Agent: COGNIAT, Eric; IAM Department Avenue Nestlé 55 CH-1800 Vevey (CH)
Priority Data:
12162370.6 30.03.2012 EP
Title (EN) 4-OXO-2-PENTENOIC ACID AND LIVER DISORDERS
(FR) ACIDE 4-OXO-2-PENTÉNOÏQUE ET TROUBLES HÉPATIQUES
Abstract: front page image
(EN)The present invention relates generally to compositions with a health benefit. In particular, the invention relates to treatment or prevention of liver disorders.A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of liver disorders. A further subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of liver disorders linked to an insufficient activity of phase II enzymes in the liver.
(FR)La présente invention concerne d'une manière générale des compositions ayant un effet bénéfique sur la santé. En particulier, l'invention concerne le traitement ou la prévention de troubles hépatiques. Un objet de l'invention est une composition qui comprend de l'acide 4-oxo-2-penténoïque à utiliser dans le traitement ou la prévention de troubles hépatiques. Un autre objet de l'invention est une composition qui comprend de l'acide 4-oxo-2-penténoïque à utiliser dans le traitement ou la prévention de troubles hépatiques liés à une activité insuffisante d'enzymes de phase II dans le foie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)